Register and attend talks from ALL FOUR Programs!

Please join us for a truly enlightening experience at our 9th Spring Meeting, which will be held March 4–6, 2019 in Norfolk, Virginia.

All of our programs are focused on providing real data and detailed methods for which you’ll learn and share scalable technologies with the individuals and organizations you want to learn from. You’ll participate in the most valuable and challenging discussions on the development and production of the industry’s most difficult applications including viral gene vectors, extracellular vesicles, cellular therapies, viral vaccines, and products derived with baculovirus technology. You can attend any talk you choose from the four concurrent programs, plus you’ll participate in a number of fun and stimulating networking events throughout the meeting that you can attend at no additional cost. This meeting offers unique opportunities to share technology with some of the most talented people in the biotech industry, plus key regulators and essential supply firms.

Real Data and Detailed Methods You Need
from the People and Organizations You Want to Learn From

Attend talks from ALL FIVE Programs!

Please join us for The Waterside Conference™ on the development and production of therapeutic proteins including antibodies, Fc fusion proteins, enzymes, cytokines, hormones, and growth factors. We’re relaunching this well-respected conference which was one of the industry’s largest, and best known, from 1996 to 2008. The 2019 conference will be held in the Waterside District of Norfolk, Virginia where we held the first meeting.

We’ll feature 5 concurrent programs to cover topics such as:

  • Cell Line Development and Banking
  • Cryopreservation
  • Scale-Up plus Scale-Down Models
  • Media & Buffer Development
  • Feed & Harvest Strategies
  • Continuous Processing & Optimization
  • Viral and Host Cell Protein Clearance
  • Raw Material Management
  • Process Analysis and Automation
  • Single-Use Components and Systems
  • Clarification and Purification
  • Characterization & Comparability
  • CDMO Management
  • Antibody / Drug Conjugation
  • Cell-Based and Potency Assays
  • Regulatory Considerations